Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Sell
47
JDOC Quote, Financials, Valuation and Earnings
Last price:
$49.66
Seasonality move
:
4.13%
Day range:
$49.93 - $50.03
52-week range:
$47.67 - $63.49
Dividend yield:
5.63%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
692
Avg. volume:
166
1-year change:
-17.29%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
$50.03 | -- | -- | -- | $0.33 | 5.63% | -- |
|
BMED
iShares Health Innovation Active ETF
|
$24.94 | -- | -- | -- | $0.01 | 0% | -- |
|
HART
NYLI Healthy Hearts ETF
|
$29.67 | -- | -- | -- | $0.17 | 1.57% | -- |
|
IXJ
iShares Global Healthcare ETF
|
$84.70 | -- | -- | -- | $0.76 | 1.63% | -- |
|
IYH
iShares US Healthcare ETF
|
$55.72 | -- | -- | -- | $0.17 | 1.37% | -- |
|
PPH
VanEck Pharmaceutical ETF
|
$86.26 | -- | -- | -- | $0.61 | 2.26% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | 0.568 | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | 0.902 | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | 0.673 | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | 0.492 | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | 0.499 | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | 0.308 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- | -- |
JPMorgan Healthcare Leaders ETF vs. Competitors
-
Which has Higher Returns JDOC or BMED?
iShares Health Innovation Active ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat iShares Health Innovation Active ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- BMEDiShares Health Innovation Active ETF-- -- -- -
What do Analysts Say About JDOC or BMED?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Health Innovation Active ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than iShares Health Innovation Active ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than iShares Health Innovation Active ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 BMEDiShares Health Innovation Active ETF0 0 0 -
Is JDOC or BMED More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Health Innovation Active ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock JDOC or BMED?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.63%. iShares Health Innovation Active ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. iShares Health Innovation Active ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or BMED?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than iShares Health Innovation Active ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than iShares Health Innovation Active ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while iShares Health Innovation Active ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for iShares Health Innovation Active ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- BMEDiShares Health Innovation Active ETF-- -- -- --
-
Which has Higher Returns JDOC or HART?
NYLI Healthy Hearts ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat NYLI Healthy Hearts ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- HARTNYLI Healthy Hearts ETF-- -- -- -
What do Analysts Say About JDOC or HART?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand NYLI Healthy Hearts ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than NYLI Healthy Hearts ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than NYLI Healthy Hearts ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 HARTNYLI Healthy Hearts ETF0 0 0 -
Is JDOC or HART More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NYLI Healthy Hearts ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock JDOC or HART?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.63%. NYLI Healthy Hearts ETF offers a yield of 1.57% to investors and pays a quarterly dividend of $0.17 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. NYLI Healthy Hearts ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or HART?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than NYLI Healthy Hearts ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than NYLI Healthy Hearts ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while NYLI Healthy Hearts ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for NYLI Healthy Hearts ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- HARTNYLI Healthy Hearts ETF-- -- -- --
-
Which has Higher Returns JDOC or IXJ?
iShares Global Healthcare ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat iShares Global Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- IXJiShares Global Healthcare ETF-- -- -- -
What do Analysts Say About JDOC or IXJ?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Global Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than iShares Global Healthcare ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than iShares Global Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 IXJiShares Global Healthcare ETF0 0 0 -
Is JDOC or IXJ More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Global Healthcare ETF has a beta of 0.676, suggesting its less volatile than the S&P 500 by 32.448%.
-
Which is a Better Dividend Stock JDOC or IXJ?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.63%. iShares Global Healthcare ETF offers a yield of 1.63% to investors and pays a quarterly dividend of $0.76 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. iShares Global Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or IXJ?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than iShares Global Healthcare ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than iShares Global Healthcare ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while iShares Global Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for iShares Global Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- IXJiShares Global Healthcare ETF-- -- -- --
-
Which has Higher Returns JDOC or IYH?
iShares US Healthcare ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat iShares US Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- IYHiShares US Healthcare ETF-- -- -- -
What do Analysts Say About JDOC or IYH?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than iShares US Healthcare ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than iShares US Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 IYHiShares US Healthcare ETF0 0 0 -
Is JDOC or IYH More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares US Healthcare ETF has a beta of 0.671, suggesting its less volatile than the S&P 500 by 32.885%.
-
Which is a Better Dividend Stock JDOC or IYH?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.63%. iShares US Healthcare ETF offers a yield of 1.37% to investors and pays a quarterly dividend of $0.17 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. iShares US Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or IYH?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than iShares US Healthcare ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than iShares US Healthcare ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while iShares US Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for iShares US Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- IYHiShares US Healthcare ETF-- -- -- --
-
Which has Higher Returns JDOC or PPH?
VanEck Pharmaceutical ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat VanEck Pharmaceutical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- PPHVanEck Pharmaceutical ETF-- -- -- -
What do Analysts Say About JDOC or PPH?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand VanEck Pharmaceutical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than VanEck Pharmaceutical ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than VanEck Pharmaceutical ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 PPHVanEck Pharmaceutical ETF0 0 0 -
Is JDOC or PPH More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison VanEck Pharmaceutical ETF has a beta of 0.588, suggesting its less volatile than the S&P 500 by 41.158%.
-
Which is a Better Dividend Stock JDOC or PPH?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.63%. VanEck Pharmaceutical ETF offers a yield of 2.26% to investors and pays a quarterly dividend of $0.61 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. VanEck Pharmaceutical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or PPH?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than VanEck Pharmaceutical ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than VanEck Pharmaceutical ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while VanEck Pharmaceutical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for VanEck Pharmaceutical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- PPHVanEck Pharmaceutical ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
80
SOC alert for Jul 18
Sable Offshore [SOC] is up 11.86% over the past day.
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 5.56% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.31% over the past day.
